Analyst Ratings for INmune Bio Inc. (INMB)
INMB Rating Summary
INMB Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$9.00 (+455.6%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
Avg. $ Target:
$9.00 (+455.6%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/11/2026 | Lucid Capital Markets | Elemer Piros | Upgrade | Buy (Neutral) |
9.00 (N/A) |
1.28 (1.62) |
26.56% | Details |
| 7/1/2025 | Scotiabank | George Farmer | Downgrade | Sector Underperform (Sector Outperform) |
0.60 (23.00) |
5.33 (1.62) |
-69.61% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
